ccc_R08

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

ccc_R08 是一种无细胞毒性且口服有效的 cccDNA 抑制剂，可降低 HBV 感染小鼠肝脏中的 cccDNA 水平。ccc_R08 可用于 HBV病毒 (乙型肝炎病毒) 感染的研究。

ccc_R08 is a non-cytotoxic and orally active cccDNA inhibitor that reduces cccDNA levels in the liver of HBV-infected mice. ccc_R08 can be used in the study of HBV virus (hepatitis B virus) infection.

ccc_R08 (0.3, 1.0, 3.2, 10, 32 μM; 5 days) significantly reduces the level of cccDNA, protein-free RC-DNA, and double stranded linear DNA (DL-DNA) in HepDES19 cells.ccc_R08 (0-100 μM) dose-dependently reduces the level of extracellular HBeAg from HepDES19 cells, with IC50 of ~0.1 μM.Western Blot Analysis Cell Line:HepDES19 cells Concentration:0.3, 1.0, 3.2, 10, 32 μM Incubation Time:5 days Result:Reduced the level of cccDNA, protein-free RC-DNA, and double stranded linear DNA (DL-DNA).

ccc_R08 (20 mg/kg; p.o.; twice per day for 2 weeks) clears cccDNA from the liver of HBVcircle mice.ccc_R08 (10, 15, 20, 30 mg/kg; p.o.; twice per day for 2 weeks) significantly decreases the serum level of pgRNA in a dose-dependent manner, and the reduction in pgRNA is quantitatively correlated with that in liver cccDNA at different doses.Animal Model:HBVcircle mouse model .Dosage:20 mg/kg Administration:Oral administration; twice per day for 2 weeks Result:Led to the clearance of cccDNA from HBVcircle mouse livers.Animal Model:HBVcircle mouse model .Dosage:10, 15, 20, 30 mg/kg Administration:Oral administration; twice per day for 42 days Result:Led to a sustained reduction in the serum levels of pgRNA.

——

Microbiology/Virology

HBV

HBV

——

——

2919019-72-8

414.84

C22H19ClO6

>98% (HPLC)

In Vitro:?DMSO 中的溶解度 : 100 mg/mL (241.06 mM; 超声助溶 )

O=C(O)C1CC(OCCOC=2C=CC(=CC2)C=3OC=4C(Cl)=CC=CC4C(=O)C3)C1

——

(-20℃)

With Ice Pack

≥ 2 years